Ameriprise Financial
AMP
$520.06
+0.02%
Ameriprise Financial is a diversified financial services holding company whose core business is advice and wealth management, supported by a large asset management franchise (Columbia Threadneedle) and a retirement and protection solutions segment that sells insurance products to advisory clients. The firm is one of the larger US-based wealth managers, with roughly 10,600 affiliated and employee advisors and approximately $1.69 trillion in assets under management and advisory across segments at year-end 2025, giving it a scale-driven, fee-based identity distinct from pure asset managers or pure insurers. The current investor debate centers on the durability of fee revenue tied to market levels and asset flows, the margin contribution from Columbia Threadneedle amid industry-wide fee pressure, and whether the retirement and protection book can sustain its earnings contribution as rates and equity markets fluctuate. Recent quarterly results showed revenue growth of roughly 5% year over year with net income of $1.126 billion, but the stock has de-rated sharply from its summer highs, and sell-side sentiment has turned more cautious, with at least one notable downgrade to Underperform in October 2026.…
AMP
Ameriprise Financial
$520.06
Investment Opinion: Should I buy AMP Today?
Rating: Hold. The core thesis is that AMP is a high-quality, capital-light fee franchise trading at a genuinely cheap 9.72x forward PE and 13.29x trailing PE, but the near-term evidence — 4.99% revenue growth, roughly 490 basis points of gross-margin compression since Q4 2025, and a negative institutional drift including B of A's October 2026 downgrade to Underperform — does not yet justify a Buy. The analyst consensus of "hold" with a recommendation mean of 2.71 and an average target of $545.18 (8.7% upside) frames the stock as fairly-to-modestly undervalued rather than mispriced. Supporting evidence is strong on profitability and cash: Q3 2026 net income of $1.126 billion was up 23.5% year over year on a 22.0% net margin, operating margin reached 29.5%, trailing free cash flow is $7.381 billion against Q3 capex of just $42 million, and ROE is 54.4%. The valuation is undemanding at 2.46x price-to-sales, 8.38x EV/EBITDA, and a PEG of 1.39, with the 13.29x trailing multiple sitting in the lower-middle of a historical band that ran from 9.87x in Q3 2026 to 23.08x in Q3 2024. The biggest risks that could invalidate the thesis are a continued slide in gross margin toward the mid-40s (which would undercut the 22% net margin), a cut to the $68.73 consensus EPS estimate that would re-rate the forward multiple higher on lower earnings, and a broad equity drawdown that hits both fee revenue and the multiple given the 1.118 beta. This Hold would upgrade to Buy if gross margin stabilizes above 50% for two consecutive quarters while revenue growth re-accelerates above 6%, or if the stock pulls back toward the $447 analyst low target with estimates intact; it would downgrade to Sell if gross margin breaks below 45% or consensus EPS is cut by more than 5%. Verdict: fairly valued to modestly undervalued relative to its own history, but not yet a compelling entry given the margin trajectory and negative estimate-revision risk.
Sign up to view all
AMP 12-Month Price Forecast
The forward-looking view is balanced: valuation at 9.72x forward earnings and 8.38x EV/EBITDA is undemanding for a business with a 22.0% net margin, 54.4% ROE, and $7.381 billion of trailing free cash flow, and the 13.29x trailing multiple sits in the lower-middle of a historical band that peaked at 23.08x. Against that, the operating trend is deteriorating — gross margin has fallen roughly 490 basis points since Q4 2025 and revenue growth has halved from roughly 9% to 4.99% — and the sell-side drift is negative with a 2.71 recommendation mean and B of A's October 2026 downgrade to Underperform. The $545.18 average target implies only 8.7% upside, so the consensus itself does not see a large re-rating catalyst, and the 43% spread between the $447 low and $638 high targets signals genuine disagreement about the earnings trajectory. I would upgrade to bullish if gross margin stabilizes above 50% for two consecutive quarters with revenue growth back above 6%, and downgrade to bearish if gross margin breaks below 45% or consensus EPS is cut by more than 5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ameriprise Financial's 12-month outlook, with a consensus price target around $545.18 and implied upside of +4.8% versus the current price.
Average Target
$545.18
14 analysts
Implied Upside
+4.8%
vs. current price
Analyst Count
14
covering this stock
Price Range
$447 - $638
Analyst target range
Coverage is moderate with 11 analysts, and the distribution is cautious: 4 Buy, 8 Hold, and 2 Sell, yielding a consensus recommendation of "hold" and a recommendation mean of 2.71 (where 3.0 is a pure hold). The average target price is $545.18, which implies roughly 8.7% upside from the current $501.49, a modest but positive signal that leans neutral-to-slightly-bullish rather than conviction bullish. The target range is wide, from a low of $447.00 (about 10.9% downside) to a high of $638.00 (about 27.2% upside), a spread of roughly 43% of the current price that signals meaningful disagreement about the earnings trajectory. The high target likely assumes multiple expansion back toward the mid-teens PE and sustained asset gathering with stable margins, while the low target prices in margin compression and slower flows; the institutional ratings show a clear negative drift, with B of A Securities downgrading to Underperform from Buy in October 2026 and Morgan Stanley maintaining Underweight, offset only by Argus Research's Buy and RBC's Outperform. The wide spread and recent downgrades argue for treating the consensus target as a soft signal rather than a strong catalyst, and the estimated EPS average of $68.73 against a forward PE of 9.72x implies the market is discounting those estimates.
Bulls vs Bears: AMP Investment Factors
The bear case currently has slightly stronger near-term evidence: revenue growth has decelerated to 4.99%, gross margin has compressed roughly 490 basis points from Q4 2025 to Q3 2026, and the institutional rating drift is negative with a B of A downgrade to Underperform and Morgan Stanley at Underweight. The bull case rests on valuation and cash generation rather than momentum — a 9.72x forward PE, $7.381 billion of trailing free cash flow, 54.4% ROE, and a 13.29x trailing multiple in the lower-middle of a historical band that peaked at 23.08x. The single most important tension is whether the 22% net margin is durable: if SG&A discipline continues to offset gross-margin compression, the low forward multiple is a value opportunity; if gross margin keeps sliding toward the mid-40s, the market's skepticism is justified and the $447 low target comes into play. With the stock at 52.6% of its range and a beta of 1.118, the risk/reward is balanced rather than compelling in either direction.
Bullish
- Forward PE of 9.7x is deeply discounted: AMP trades at a forward PE of 9.72x against a trailing PE of 13.29x, a roughly 27% gap that implies the market is already discounting the $68.73 consensus EPS estimate. For a business generating a 22.0% net margin and 54.4% ROE, that multiple embeds significant skepticism that may prove excessive if earnings hold.
- Profitability inflected sharply higher in 2026: Net margin rose from 18.7% in Q1 2026 to 22.2% in Q2 and 22.0% in Q3, while operating margin climbed from 25.1% to 30.4% to 29.5% over the same quarters. Q3 net income of $1.126 billion was up 23.5% year over year from $912 million, showing operating leverage is flowing through despite softer revenue growth.
- Massive free cash flow and capital returns: Trailing free cash flow is $7.381 billion, with Q3 operating cash flow of $1.519 billion against capex of only $42 million. The company returned $915 million via buybacks and dividends in Q3 alone at a payout ratio of just 16.7%, leaving ample capacity to keep shrinking the share count (90.3 million shares vs. 96.3 million a year ago).
- Valuation sits in lower-middle of historical band: The current 13.29x trailing PE compares with 9.87x in Q3 2026, 11.53x in Q4 2025, 12.97x in Q3 2025, and a peak of 23.08x in Q3 2024. At 2.46x price-to-sales and 8.38x EV/EBITDA, the stock is not priced for optimism, which limits multiple-compression downside if flows stabilize.
Bearish
- Revenue growth decelerating toward mid-single digits: Year-over-year revenue growth slowed from roughly 9% in Q1 2026 to 4.99% in Q3 2026 ($5.117 billion vs. $4.874 billion). With Advice and Wealth Management at 67% of revenue ($3.445 billion) and fee revenue tied to market levels, the deceleration suggests asset-market tailwinds are fading.
- Gross margin compression is persistent: Gross margin fell from 53.6% in Q4 2025 to 50.3% in Q1 2026, 44.7% in Q2, and 48.7% in Q3 2026. The trend reflects fee pressure at Columbia Threadneedle and a mix shift toward lower-margin segments, and while SG&A discipline has offset it at the net line, that offset has limits.
- Sell-side sentiment has turned negative: Of 11 analysts, only 4 rate Buy versus 8 Hold and 2 Sell, for a recommendation mean of 2.71. B of A Securities downgraded to Underperform from Buy in October 2026 and Morgan Stanley maintains Underweight, a negative drift that typically precedes estimate cuts rather than follows them.
- Stock is a damaged uptrend mid-range: At $501.49, AMP sits at just 52.6% of its $422.37-$572.56 52-week range, down 9.15% over three months despite a 2.23% one-month bounce, with a 21.1% maximum drawdown from the summer highs. The September-October slide from the $570s to the $480s broke the momentum and left heavy resistance in the $540-$560 congestion zone.
AMP Technical Analysis
AMP is in a recovery phase within a broader, still-positive one-year uptrend: the stock is up 9.61% over the past year but sits at $501.49, which is roughly 52.6% of its 52-week range of $422.37 to $572.56. That mid-range positioning reflects a stock that has given back a meaningful portion of its summer gains rather than one pressing against highs, and the 21.1% maximum drawdown confirms a sharp correction occurred. The stock is neither a momentum leader at highs nor a falling knife at lows, but a damaged uptrend that has stabilized. Recent momentum is mixed and diverging from the longer-term trend: the stock is up 2.23% over the past month but down 9.15% over three months, while the one-year change remains a positive 9.61%. That pattern — a three-month drawdown followed by a one-month bounce — is consistent with mean reversion after the September-October selloff from the $570 area down to the $480s, and the relative strength figures reinforce the divergence, with 1-month relative strength of +7.22% against SPY versus -4.24% over three months. Key levels are clear: support sits near the 52-week low of $422.37, with intermediate support around the October lows near $480, while resistance is the 52-week high of $572.56 and the $540-$560 congestion zone from August-September. A breakout above $572.56 would signal the correction is over and reassert the uptrend, whereas a breakdown below $480 would put the $422.37 low in play; with a beta of 1.118, AMP is about 12% more volatile than the market, which argues for modestly smaller position sizing and wider stops than a market-beta name.
Beta
1.12
1.12x market volatility
Max Drawdown
-21.1%
Largest decline past year
52-Week Range
$422-$573
Price range past year
Annual Return
+11.9%
Cumulative gain past year
| Period | AMP Return | S&P 500 |
|---|---|---|
| 1m | +4.0% | -2.4% |
| 3m | -8.9% | -2.3% |
| 6m | +10.6% | +2.8% |
| 1y | +11.9% | +11.3% |
| ytd | +5.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMP Fundamental Analysis
Revenue is growing at a steady but moderating pace: Q3 2026 revenue was $5.117 billion, up 4.99% year over year from $4.874 billion, and the multi-quarter trend shows sequential growth from $4.886 billion in Q1 to $5.013 billion in Q2 to $5.117 billion in Q3, with the year-over-year comparison improving from roughly 9% in Q1 2026 (versus $4.483 billion) to about 5% by Q3. Segment data shows Advice and Wealth Management at $3.445 billion is the dominant revenue driver, roughly 67% of the total, with Asset Management at $990 million and Retirement and Protection at $997 million providing diversification but far less scale. The growth trajectory supports a stable, fee-driven franchise rather than a high-growth story, and the deceleration from Q1's pace to Q3's ~5% suggests market-level tailwinds are fading. Profitability is robust: Q3 2026 net income was $1.126 billion on a 22.0% net margin, with gross margin of 48.7% and operating margin of 29.5%, and the trend is improving — net margin rose from 18.7% in Q1 2026 to 22.2% in Q2 and 22.0% in Q3, while operating margin climbed from 25.1% to 30.4% to 29.5%. Gross margin, however, has compressed from 53.6% in Q4 2025 to 48.7% in Q3 2026, a trend worth monitoring, though the operating leverage from SG&A discipline (Q3 SG&A of $982 million) has more than offset it at the net line. The balance sheet and cash generation are strong: trailing free cash flow is $7.381 billion, Q3 operating cash flow was $1.519 billion against capex of just $42 million, and the debt-to-equity ratio of 0.895 is moderate for a financial. ROE of 54.4% is exceptionally high, reflecting the capital-light, fee-based model and an equity base that is small relative to assets, while the current ratio of 25.8 signals ample liquidity; the company is clearly self-funding, returning capital via $915 million of Q3 buybacks and dividends, with a payout ratio of just 16.7%.
Quarterly Revenue
$5.1B
2026-09
Revenue YoY Growth
+5.0%
YoY Comparison
Gross Margin
48.7%
Latest Quarter
Free Cash Flow
$7.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMP Overvalued?
Because net income is positive ($1.126 billion in Q3 2026), the PE ratio is the appropriate primary metric. AMP trades at a trailing PE of 13.29x and a forward PE of 9.72x, and the wide gap between the two implies the market expects meaningful earnings growth — the forward multiple of 9.72x is roughly 27% below the trailing 13.29x, a discount that suggests either conservative guidance or skepticism about earnings durability. On a peer basis, a 13.3x trailing PE and 9.7x forward PE are low in absolute terms for a financial with 22% net margins and 54% ROE, and the 2.46x price-to-sales and 1.89x EV-to-sales multiples are modest relative to the 50.4% gross margin; the PEG ratio of 1.39 is reasonable but not cheap, and the 8.38x EV/EBITDA is undemanding. The premium/discount question is less about the sector than about the market's willingness to pay for fee-based asset gathering at a time when flows and market levels are uncertain, and the low forward multiple suggests the market is pricing in limited multiple expansion. Historically, AMP's PE has ranged widely: it was 9.87x in Q3 2026, 11.53x in Q4 2025, 12.97x in Q3 2025, and as high as 23.08x in Q3 2024, so the current 13.29x trailing multiple sits in the lower-middle of its own multi-year band. That positioning suggests the market is not pricing in optimistic expectations — if anything, the stock is near the cheaper end of its historical range, which could represent a value opportunity if earnings hold, or reflect fundamental concerns about growth deceleration and margin compression.
PE
13.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~17x
vs. Industry Avg
16.3x
Industry PE ~16.3x*
EV/EBITDA
8.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin durability and revenue concentration. Gross margin has fallen from 53.6% in Q4 2025 to 48.7% in Q3 2026, a roughly 490 basis point compression that, if it continues, would erode the 22.0% net margin that currently justifies the valuation. Advice and Wealth Management contributes $3.445 billion, or about 67% of the $5.117 billion quarterly revenue, so a market-level decline or advisor attrition directly hits the dominant profit pool, and revenue growth has already decelerated from roughly 9% in Q1 2026 to 4.99% in Q3. The debt-to-equity ratio of 0.895 is moderate and the current ratio of 25.8 signals ample liquidity, but the 54.4% ROE is flattered by a small equity base, meaning book-value-based downside protection is thinner than the headline profitability suggests. Market and competitive risks are dominated by multiple compression and fee pressure. At a 13.29x trailing PE and 9.72x forward PE, AMP is cheap in absolute terms, but the 27% trailing-to-forward gap means the market is already pricing limited earnings durability; if the $68.73 consensus EPS estimate is cut, the forward multiple re-rates higher on lower earnings and the stock de-rates twice. Columbia Threadneedle's $678 billion asset management franchise faces industry-wide fee pressure that shows up directly in the gross-margin trend, and with a beta of 1.118 the stock is about 12% more volatile than the market, so a broad equity drawdown hits both fee revenue and the multiple simultaneously. The negative institutional drift — B of A's October 2026 downgrade to Underperform and Morgan Stanley's Underweight — raises the risk that further estimate cuts trigger additional downgrades. The worst-case scenario is a compounding chain: equity markets decline, advisory fee revenue and flows weaken, gross margin slides further into the mid-40s, consensus EPS of $68.73 gets cut, and the stock re-tests its 52-week low of $422.37, which is 15.8% below the current $501.49. A deeper break toward the $447.00 analyst low target would represent roughly 10.9% downside, and the 21.1% maximum drawdown already observed this year shows the stock can move that far quickly; a full retracement to the 52-week low plus a modest overshoot would put losses in the -16% to -20% range from here, with the $480 October support level as the first tripwire that would confirm the adverse path.
FAQ
The most severe risk is margin erosion: gross margin has fallen from 53.6% in Q4 2025 to 48.7% in Q3 2026, and a continued slide into the mid-40s would undercut the 22.0% net margin that anchors the valuation and put the $447.00 analyst low target in play. Second is estimate-revision risk — with only 4 Buy ratings against 8 Hold and 2 Sell (recommendation mean 2.71), B of A's October 2026 downgrade to Underperform and Morgan Stanley's Underweight raise the odds that a cut to the $68.73 consensus EPS re-rates the forward multiple higher on lower earnings. Third is market sensitivity: with beta of 1.118 and 67% of revenue from Advice and Wealth Management tied to asset levels, a broad equity drawdown hits fee revenue and the multiple simultaneously, and the 21.1% maximum drawdown this year shows how fast that can happen. Fourth is company-specific flow and competitive pressure at Columbia Threadneedle's $678 billion asset management franchise, where industry-wide fee pressure is already visible in the gross-margin trend. Ranked by severity: margin erosion first, estimate cuts second, market beta third, and asset-management fee pressure fourth.
The 12-month forecast is split roughly 50/25/25 across base, bull, and bear cases. The base case (50% probability) targets $520-$545.18, assuming revenue growth holds at 4-5%, gross margin stabilizes in the high-40s, and the $68.73 consensus EPS is met, allowing a drift toward the $545.18 average target for about 8.7% upside. The bull case (25%) targets $572.56-$638.00 and requires gross margin back above 50%, revenue growth above 6%, and a broker upgrade cycle reversing the recent downgrades. The bear case (25%) targets $422.37-$447.00, driven by an equity-market decline, gross margin into the mid-40s, and a cut to consensus EPS. The base case is most likely because it requires only that current trends stabilize rather than reverse, and the 9.72x forward multiple leaves room for modest recovery without estimate upgrades. The key assumption behind the base case is that SG&A discipline (Q3 SG&A of $982 million) continues to offset gross-margin compression at the net line.
AMP screens as modestly undervalued on absolute and historical measures. The trailing PE of 13.29x and forward PE of 9.72x sit in the lower-middle of a multi-year band that ran from 9.87x in Q3 2026 to 23.08x in Q3 2024, and the 27% trailing-to-forward gap implies the market is already discounting the $68.73 consensus EPS estimate. Supporting metrics are undemanding: 2.46x price-to-sales, 8.38x EV/EBITDA, and a PEG of 1.39, against a 50.4% gross margin and 22.0% net margin. The caveat is that the low multiple may be rational rather than a mispricing — it reflects decelerating revenue growth (4.99%) and roughly 490 basis points of gross-margin compression since Q4 2025, which is exactly the kind of deterioration that compresses financial-sector multiples. The market appears to be pricing limited earnings durability rather than optimism, so the stock is fairly valued to modestly undervalued relative to its own history, but not deeply discounted relative to the risk in the margin trend.
From a risk/reward perspective, AMP offers a modestly favorable but not compelling setup: the $545.18 average analyst target implies 8.7% upside, while the $447.00 low target implies 10.9% downside, so the skew is roughly balanced rather than asymmetric. The valuation is genuinely cheap at 9.72x forward earnings and 8.38x EV/EBITDA for a business with a 22.0% net margin and 54.4% ROE, and $7.381 billion of trailing free cash flow funds a 16.7% payout ratio and continued buybacks. Against that, the operating trend is negative — gross margin has compressed roughly 490 basis points since Q4 2025 and revenue growth has halved to 4.99% — and the sell-side drift includes B of A's October 2026 downgrade to Underperform and Morgan Stanley's Underweight. It is a reasonable buy for value-oriented investors with a 12-18 month horizon who can tolerate a 1.118 beta and a potential retest of the $480 support, particularly on a pullback toward the $447-$480 zone with estimates intact. It is not a good buy for momentum or short-term traders, given the 21.1% maximum drawdown already seen this year and the heavy $540-$560 resistance overhead.
AMP is better suited to a medium-to-long-term holding period of at least 12-18 months than to short-term trading. The stock is in a mature, fee-driven growth stage with revenue expanding at 4.99% and earnings visibility supported by a $68.73 consensus EPS estimate, a 1.28% dividend yield, and a 16.7% payout ratio that leaves room for continued buybacks — all of which favor patient ownership. Volatility is meaningful, however: beta of 1.118, a 21.1% maximum drawdown this year, and a 43% spread between the $447 low and $638 high analyst targets mean short-term price action is driven by market levels and sentiment rather than fundamentals. The stock's 9.61% one-year gain and 52.6% mid-range positioning suggest the easy recovery trade is done, so a trader would need to time the $480 support and $540-$560 resistance levels carefully. A long-term investor can accumulate on weakness toward the $447-$480 zone, collect the dividend, and let buybacks compound per-share earnings, with the gross-margin trend as the key metric to monitor each quarter.